Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IBIO compared with HLXC: revenue, margins and what each company keeps, and the suppliers and customers both name
IBIO
iBio, Inc.
Change
Mkt cap
Revenue
Revenue
HLXC
Helix Acquisition Corp. III
Change
Mkt cap
Revenue
Revenue
vs
Compare
IBIO
iBio, Inc.
vs
HLXC
Helix Acquisition Corp. III
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
IBIO: latest quarter is a loss; flow not drawable. HLXC: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
IBIO, solid
HLXC, dashed
IBIO
iBio, Inc.
Change
0.75
▼
−7.45%
· post 0.75
Mkt cap
$49.4M
Revenue
$100,000
Q1 FY26
HLXC
Helix Acquisition Corp. III
Change
10.25
▼
−0.44%
· post 10.28
Closed
Oct 30 '26
Mkt cap
$226.6M
Revenue
—
vs
Compare
Closed
Oct 30 '26
IBIO
iBio, Inc.
vs
HLXC
Helix Acquisition Corp. III
0.75
▼
−7.45%
post 0.75
Price
10.25
▼
−0.44%
post 10.28
$49.4M
Mkt cap
$226.6M
Q1 FY26
$100,000
Revenue
—
Change
Change
IBIO
0.75
▼
−7.45%
vs
HLXC
10.25
▼
−0.44%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IBIO
16
TWST
Twist Bioscience
supplier
—
AstralBio
unlisted
supplier
—
Chardan
unlisted
supplier
—
Lonza Sales
unlisted
supplier
12 more · IBIO chain
›
Shared
0
No disclosed counterparties: HLXC.
Only HLXC
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR